INTRODUCTION
Glial cell line-derived neurotrophic factor (GDNF) was initially identified for its ability to promote survival of midbrain dopamine neurons (1) and its neurotrophic actions have been extensively studied in animal models of Parkinson's disease (2) . However, its actions are not specific for dopamine neurons, GDNF regulates neurite branching, synaptic plasticity, and phenotypes of several neuronal populations (3) . Exogenous GDNF supports survival of noradrenergic neurons (4) , spinal motor neurons (5, 6) , peripheral sensory and autonomic neurons (7) , forebrain cholinergic and GABAergic neurons (8) and pancreatic -cells (9) . Furthermore, GDNF protects the brain from ischemic injury (10) and ameliorate neuropathic pain (11) . In peripheral tissues, GDNF promotes differentiation of kidney, lung, pancreas, germ cells, myocytes, thymocytes, and influences gastrointestinal inflammation and tumorigenesis (12) (13) (14) (15) (16) (17) (18) (19) .
GDNF is synthesized in a precursor form, pre-pro-GDNF, that is processed into the mature form, packaged into vesicles and released upon neuronal activity (1) . Previous studies have shown that the human and rodent GDNF genes have three exons encoding two mRNAs that are produced by alternative splicing of exon 2: pre-()longpro-GDNF and pre-()short-pro-GDNF with the ()short isoform lacking 26 amino acids in the pro-region (7, (20) (21) (22) . Recent studies have indicated that both forms are secreted from neurons, but secretion of the ()shortpro-GDNF and its mature GDNF is activity-dependent whereas ()long-pro-GDNF and its mature GDNF are secreted constitutively in an adrenal gland pheochromocytoma PC-6.3 cell line (23) .
Site-directed mutagenesis has shown that the pro-region and C-terminal cysteines are important for GDNF processing and secretion (24) . Pre-pro-GDNF processing and secretion are not well studied with respect to the different isoforms, especially in humans where isoforms are more heterogeneous in pre-pro-regions than in those of the rodent. Using an EST database search following RT-qPCR in different human tissues, we identified three additional human exons that produce GDNF isoforms and a cis-natural antisense transcript (cis-NAT), termed GDNFOS, transcribed from the opposite strand of the GDNF gene (25) . One of the GDNFOS isoforms encodes a potentially secreted peptide of 105 amino acids detected in human kidney cell lines and brain by Western blot analysis. Therefore, it may be that human and rodent GDNF isoforms differ in several aspects, the number of exons, alternative splicing, signal peptides, cis-NAT regulation, but also differ at the levels of expression in brain and peripheral tissue.
GDNF is known to be downregulated in substantia nigra and putamen in human Parkinson's disease (26) (27) (28) ; however GDNF regulation in Alzheimer's disease (AD) is less documented (29) . A recent report indicated that GDNF concentrations are significantly up-regulated in cerebrospinal fluid and down-regulated in serum in patients with early AD (30) . We selected human middle temporal gyrus (MTG) for GDNF study because it is a region consistently affected by Alzheimer's disease (31) and neurons of the MTG are also affected in HD (32) . We found that the mRNA deriving from human GDNF exon 2 was significantly increased while the mature peptide was decreased in the MTG of AD patients in comparison with MTG of agematched controls. To the best of our by guest on October 30, 2017 http://www.jbc.org/ Downloaded from knowledge, this is the first investigation of regulation of human GDNF and GDNFOS isoforms and mature GDNF peptide in the brains of AD and HD patients
EXPERIMENTAL PROCEDURES
Bioinformatic analysis of GDNF and GDNFOS isoforms -Based on our study of the role of GDNF in incubation of heroin craving (33), we found that the human GDNF gene contains more spliced ESTs in the UCSC genome browser (http://genome.ucsc.edu/) than rat. We searched the human expressed sequence tag (EST) data base: (http://www.ncbi.nlm.nih.gov/dbEST/index. html) to identify additional human GDNF exons. We found human exons 1, 4 and 6 to be homologous to rat exons 1, 2 and 3, respectively. Using Sequencher software (Gene Code Corporation, Ann Arbor, MI), we identified additional human exons 2, 3 and 5 that are aligned to the EST clones and human GDNF genomic sequence. Human GDNF isoform nucleotide sequences were translated into amino acid sequences using the ExPASy translation tool (http://us.expasy.org/tools/dna.html) and the peptide sequences were aligned using CLUSTALW software (http://www.ebi.ac.uk/Tools/msa/clustalw2/). In addition, we also identified a natural antisense gene (GDNFOS: GDNF Opposite Strand) transcribed from the antisense strand of GDNF gene by EST sequence alignments and Sanger sequencing (Eurofins, Huntsville, AL) of three IMAGE human cDNA clones. The pre-pro-GDNF domains and potential post-translational modification sites were identified by InterProScan (http://www.ebi.ac.uk/interpro/). Based on the possible isoform differences between rat and human, the evolutionary analysis of the splicing junctions was carried out in UCSC syntenic genomic alignment using BLASTZ followed by chaining and netting pipeline (34) (35) (36) figure 1A ) whereas the goat GDNF antibody (AF-212-NA, R&D Systems, Minneapolis, MN) recognized the specific GDNF dimer and monomer of rat tissue extracts (S- figure 1B ). An affinity purified anti-GDNFOS3 antibody was developed by injecting rabbit with epitope peptide (CKGMSHGQHFTHT) located at the Cterminus (Genemed Synthesis, Inc. San Antonio, TX) and was used for Western blot of HEK293 and SH-SY5Y, CHO cell lines and tissues of human and rat. The Western blocking solutions for GDNF and GDNFOS were 5% and 7.5% non-fat milk, respectively, to show the specific immunostainings. Student's t-test was used to analyze Western blot data.
RESULTS
Human GDNF gene has six exons and multiple isoforms -A search of the human dbEST database followed by RTqPCR analysis identified six exons in the human GDNF gene ( Figure 1A ). A comparison with the rat GDNF gene structure reveals that three exons, human GDNF exons 1, 4short, 4long, and 6 are conserved with rat GDNF exons 1, 2short, 2long, and 3, respectively. The human GDNF exons 2, 3, and 5 sequences are aligned ( Figure 1 ) with human EST clones AJ001897, AJ001899 and DQ235474, respectively.
The original translation initiation methionine of the GDNF is located in human exon 4. InterProScan (http://www.ebi.ac.uk/Tools/InterProScan/)
indicates that the GDNF isoform with exon 2 (Ex2_4L) contains another initiation codon that translates into 35 amino acid signal peptide in contrast to GDNF isoforms with exons 1 or 3 (Ex1_4S/L and Ex3_4S, respectively), which each contains 18 amino acid signal peptides (S-figure 2). The insertion of human exon 5 between exon 4 short and 6 creates a truncated GDNF isoform (Ex4S_5) which potentially utilizes the downstream initiation methionine encoded by exon 6. The truncated GDNF isoform Ex4S_5 contains only 20 amino acids of the pro-region before the furin endoproteinase cleavage site and InterProScan indicated that the 20 amino acid sequence is not a signal peptide. Therefore, human GDNF isoforms of Ex1_4L, Ex1_4S, Ex3_4S, Ex2_4L, and Ex4S_5 encode 211, 185, 185, 228, and 159 amino acids, respectively, and the peptide sequence differences among the isoforms are located in the pre-pro-regions of GDNF. All of the human GDNF isoforms encode the identical mature GDNF peptide (S-figure 2).
We investigated human GDNF isoform expression patterns in brain regions and peripheral tissues using isoform-specific TaqMan-MGB probes ( Figure 1 and S-table 2). We used the human caudate hGDNF-S mRNA as a reference. The human hGDNF-L mRNA levels were highest in intestine, kidney, pancreatic islet, caudate and putamen while the hGDNF-S mRNA levels were highest in intestine and kidney (Table 1A) .
RT-qPCR showed that human GDNF exon 1 (Ex1_4L/S) transcript level is highest in brain and peripheral tissues except for pancreatic islets where exon 2 (Ex2_4L) transcript is higher. The exon 3 (Ex3_4S) transcript was not found in most tissues except for low levels in intestine and kidney. The exon 5 (Ex4S_5) transcript was either not detected or was at very low levels in putaman, nucleus accumbens, prefrontal cortex, amygdala, hypothalamus, and intestine (Table 1A ). The ratios of the human GDNF -long and -short isoforms were generally higher in brain regions (except hypothalamus and amygdala) and pancreatic islets than the ratios of -long and -short in peripheral tissues (Table 1A) .
Comparison of rat GDNF isoform mRNA and protein tissue expression -Using specific TaqMan probes for rGDNF-L and rGDNF-S isoforms (S-table 2) and, for reference the rGDNF-S in rat dorsal striatum, we found that mRNA for rGDNF-L was expressed several fold higher than that of the rGDNF-S across brain regions and peripheral tissues. The highest mRNA expressions were in dorsal striatum and nucleus accumbens, and ovary, lung, and stomach and lower levels in prefrontal cortex and amygdala (Table 1B) . Interestingly, the human -long and -short ratios are several folds higher than rat -long and -short ratios (Tables 1A and B) . As the long pre-()long-proGDNF isoform contains the dopamine neuron stimulating peptide-11 (DNSP-11) (38, 39) , this 11mer peptide encoded transcript is expressed at higher level in human than rat brain (Sfigure 2).
We used Western blot analysis to detect both GDNF monomers and dimers using a goat polyclonal antibody (33) . We found that levels of mature GDNF monomer were higher in ventral PFC and amygdala; lower in hippocampus CA1, CA2 and dentate gyrus than in other brain regions. We also found the levels of the monomer were higher in muscle and testis than in other peripheral tissues (Figure 2A and B) . The 32 kD band was observed in rat heart, lung and spleen and the 48 kD band was observed in heart, muscle, and stomach. Since the Western blots were carried out in the same conditions for both brain and peripheral tissues, the formation of GDNF oligomerization could be stronger in peripheral tissues than that of brain ( Figure  2B in reduced and S-figure 1B in nonreduced conditions). Western blot analysis showed that GDNF peptide levels did not correlate with mRNA levels in brain regions where the striatal levels were several times higher than that of pre-frontal cortex. The discordance between GDNF mRNA and the mature peptide in different brain regions could be due to cell type specific expression of GDNF isoforms and transportation of mature peptide along neuronal processes (40) .
GDNFOS is transcribed from the opposite strand of the human GDNF geneBy searching the human dbEST database followed by RT-qPCR analysis and sequencing of the IMAGE cDNA clones, a cis-natural antisense transcript (GDNFOS) gene was identified from the opposite strand of GDNF ( Figure 1A ). The GDNFOS gene contains 4 exons and three initiation sites for transcription, i.e. exon 1, exon 2-long and exon 3-long for GDNFOS1, 2 and 3, respectively ( Figure 1B) .
The first exon of the GDNFOS1 isoform has 136 nucleotides reverse complementarity (head-to-head configuration) (25) to the 5'UTR of the GDNF isoform Ex1_4L/S ( Figure 1A) . The exon 1 of the GDNFOS1 isoform is spliced to the exon 2-short, exon 3-short (intraexonal splicing events) and exon 4-short (alternative poly adenylation event). The exon 2-long of GDNFOS2 isoform is spliced to the exon 3-short and exon 4-short. The exon3-long of GDNFOS3 isoform is spliced to exon 4-long (alternative poly adenylation event, Figure 1B) . The GDNFOS2 and GDNFOS3 transcripts do not overlap with the GDNF sense transcripts. IMAGE clones of 277201, 1762317, and 1637129 were sequenced in two directions to obtain the sequences of GDNFOS1, 2, and 3 (GenBank accession number: JF824130, JF824131, and JF824129, respectively).
GDNFOS1 and -2 IMAGE clones contain the upstream poly A site to produce 618 bp and 2,944 bp transcripts, respectively. GDNFOS1 and -2 are predicted long-noncoding RNAs (lncRNAs) (41), with no open reading frame (ORF) of more than 60 amino acids. The GDNFOS3 IMAGE clone contains the downstream alternative adenylation site to produce a 1,963 bp transcript that potentially encodes an ORF of 105 amino acids (Figure 3) . The calculated molecular weight and isoelectric point of the ORF are 11.86 kDa and pI=8. 47 Figure 1B and S-table 2 ) was designed at the splicing junction of GDNFOS gene exons 1 and 2 to investigate the tissue expression patterns of the GDNFOS1 transcript. The highest mRNA levels of GDNFOS1 were found in kidney, ovary, and testis where GDNFOS1 mRNA is more than 10 fold of that of brain caudate region; higher expression was also observed in cerebellum and nucleus accumbens relative to other brain areas ( Figure 4A ). The transcriptional level of GDNFOS1 is lower than that of GDNF isoform Ex1_4L in all brain regions (data not shown).
The affinity purified antibody against the C-terminal peptide (CKGMSHGQHFTHT) of GDNFOS3 recognized a 35 kDa band in Western blot (7.5% dry milk blocking solution) of human embryonic kidney (HEK293) and MTG but not in SH-SY5Y and Chinese hamster ovary (CHO) cell lines, rat kidney and prefrontal cortex ( Figure 4B, left) . The 35 kDa band could be blocked in HEK293 and MTG by pre-incubation of the antibody with the antigenic peptide ( Figure 4B, right) . The 35 and 30 kDa bands might be glycosylated or oligomeric form of GDNFOS3. More background was seen with less concentrated blocking solution (5% dry milk), however, the 30 kDa band was more intense and 11 kDa bands could also be observed in human HEK293 and SH-SY5Y cells and MTG but not rat kidney and prefrontal cortex and CHO cells (data not shown).
Accelerated primate evolution of GDNF/GDNFOS locus -The finding of human GDNF and GDNFOS isoforms may indicate that the locus is a primate accelerated region (43).
We used comparative genomics of the mVISTA and UCSC genome browser of the 46-way vertebrate alignments (44, 45) to examine the conservation and the distribution of the splicing structure of GDNF and GDNFOS in different species and the ORFs on the vertebrate phylogenetic tree. The GDNF/GDNFOS locus predates the vertebrate split, i.e. it is largely shared across fish and humans but absent in invertebrates.
We manually removed insertions, deletions or stop codons in non-human species and fed this codon-based alignment into CODEML (46) . As a result, we found that exon 2 of human GDNF is only shared by primates given the narrow distribution of the exon donor sequence GT in these species. The species other than primate either do not contain the translation initiation codon (ATG) or lost their exon donor sequence (Table 2) .
InterProScan predicted that GDNF exon 2 encodes an extended and primate-specific signal peptide (MQSLPNSNGAAAGRDFK) in frame with exon 4. GDNF exon 3 appears to be shared by multiple mammalian groups given the existence of GT in outgroups, suggesting it is an ancestral form. The splicing junctions (AG/GT) of GDNF exon 5 appear constrained in primate but divergent in other placental mammals. However, the exon 3 and 5 sequences were not found in EST databases of other species except for that of human.
The GDNFOS exon 1 may be unique in hominoids (human and apes) given the occurrence of the AT-GT substitutions in the splicing donor site in monkey and other mammalian genomes (Table 3) . Although GDNFOS exon 2, 3 and 4 splicing acceptor and donor sites are shared across mammals, we observed a TG-AG mutation in the splicing acceptor site of GDNFOS exon 3 in the marmoset genome. Since the ORF of GDNFOS3 was found in human, we should expect that the evolutionary branch towards human demonstrates a different ratio of nonsynonymous substitution rate and synonymous substitution rate (Ka/Ks) compared to other branches. The Ka/Ks value in human branch is 0.9, which demonstrates that GDNFOS is a hominoid young gene with coding potential (46) . Based on the species genome alignment of UCSC, GDNFOS3 translation initiation codon (ATG) is disabled in opossum, dog, mouse and orangutan and numerous indels occur in rodents (S- figure 4) . Therefore, GDNFOS3 peptide might be human and chimpanzee specific.
Primate-specific GDNF transcripts and mature GDNF peptide are dysregulated in MTG of AD -The RNA and protein qualities of the postmortem MTG samples of both controls and AD brains were tested by RNA integrity numbers (Average RIN=5.04, S-table 1A) and integrity of a single tubulin band on Western blot (Figure5A and B; S- figure 3A and B) , respectively. A two-tailed Mann-Whitney for Gaussian approximation U-test showed that there were no significant changes ( Figure 6A , B and C) in the exon 1 driven isoform, pre-()short-proGDNF transcript and GDNFOS1 transcript (Ex1_4S: p=0.411; hGDNF-S: p=0.089 and GDNFOS1: p=0.101, respectively) at the mRNA level, however, the primate exon 2 driven transcript (Ex2_4L) and pre-()longproGDNF transcript (hGDNF-L) encoding DNSP-11 mRNAs were significantly increased more than 10 fold ( Figure 6D and F) in MTG of AD in comparison with the matched controls (Ex2_4L: p=0.013 and hGDNF-L: p=0.003). The exon 3 driven isoform mRNA (Ex3_4S) could not be detected in any of the MTG samples using RT-qPCR. Interestingly, an unpaired twotailed Student t-test showed that the mature GDNF peptide of 15 and 16 kDa decreased by 50% ( Figure 5A and S-figure 3A) in AD MTG in comparison with that of controls (p=0.0241, t=2.368, df=32). We did not find any significant change at both GDNF isoform mRNA or mature peptide levels in the MTG of HD ( Figure 5B , Figure 6E and S- figure 3B ), further indication of the specificity for GDNF dysregulation in MTG of AD.
DISCUSSION
Human GDNF gene contains six exons whose alternative splicing creates five human GDNF isoforms (S- figure 2) . We have also identified human GDNFOS isoforms transcribed from opposite strand of GDNF gene. GDNFOS1 is lncRNA and overlaps with the GDNF transcript. The GDNFOS2 transcript is also lncRNA and does not overlap with GDNF transcript. GDNFOS3 has a potential ORF that encodes a protein with no known homologue in GenBank. The GDNF transctipt from exon 2 was up-regulated and the mature GDNF peptide was down-regulated in MTG of AD. The tissue expression patterns of GDNF transcripts differ greatly between human and rat. The alternative intra-exon splicings of both human and rat GDNF produces -long and -short proforms differ in 26 amino acids. However, the splicing efficiency could be quite different between the species, given that the ratios of -long and -short pro-forms in human brain are much higher than the ratios of -long and -short proforms in rat brain. Since -long GDNF isoforms potentially encodes DNSP-11 but not -short GDNF isoforms (38, 39) , the higher expression of the pre-pro()long-GDNF isoforms in human brain implies also the higher production of DNSP-11. Dysregulation of human GDNF and DNSP-11 and GDNFOS may contribute vulnerability of AD pathogenesis.
The neuroprotective effect of Memantine in Alzheimer's disease may involve GDNF up-regulation (47) as well as inhibition of the NMDA receptor. In human MTG of AD patients, the reduced mature GDNF peptide secretion might be a feedback signal for the increased humanspecific GDNF isoform mRNA expression to compensate for the loss of mature GDNF peptide secretion. On the other hand, DNSP-11 containing -long isoform upregulation might be a neuroprotective response of AD brain. We previously observed similar discordant mRNA and protein expression in AD brain for a human-specific de novo gene, C20orf203 (48) . Because the RNA integrity numbers (RIN) of the postmortem MTG samples varied between 2.2 to 7.7 with average RIN of 5.0, the observed GDNF isoform mRNA changes might not be accurately measured. Since the proteins are more stable in postmortem tissues (49) as indicated by an intact tubulin band in all of the samples (S- figure 3A and B) , the observed down-regulation of mature GDNF peptide should be more reliably measured.
BDNF and GDNF are two essential neurotrophic factors in vertebrates. BDNF plays important roles in neurodegenerative and addictive disorders (50) . There are similarities and differences in the gene structures, differential species and tissue expression patterns, pre-pro-forms, and natural antisense transcripts encoded by their opposite DNA strands (51,52). The BDNF gene alternative splicing generate 26, 18 and 33 amino acid signal peptides in BDNF isoforms transcribed from exons 1, 4 and 7, respectively (52,53). The GDNF gene alternative splicing generates 18 and 36 amino acid signal peptides in GDNF isoforms transcribed from exons 1 and 2, respectively. It can be speculated that the longer signal peptides of BDNF and GDNF may be differential targeting signals in rough endoplasmic reticulum, leading to sequestration in specific secretary compartments of the trans-Golgi-network to regulate pro-and mature peptide transport and secretion. Both human BDNF and GDNF loci contain the natural antisense transcripts of BDNFOS and GDNFOS genes (52,53) that have reverse complementarity to their sense counterparts with 224 nucleotides and 136 nucleotides, respectively. BDNFOS overlaps with the BDNF coding exon within ORF and GDNFOS overlaps with the GDNF 5'UTR exon (52). Both BDNFOS and GDNFOS genes are transcribed by RNA polymerase II, alternatively spliced, and polyadenylated (25) ; however the initiation of BDNFOS transcription is derived from a single promoter (52,53) composed of hundreds of alternatively spliced isoforms (53) while the initiation of GDNFOS gene transcription derives from three exons with fewer alternatively spliced isoforms. GDNFOS transcripts contain various retroposons of Alu, Line, MIRs, and endogenous retroviral sequences (ERVL-MalR, hAT-Charlie and TCMar-Tigger2;
RepeatMasker: http://www.repeatmasker.org/), characteristically de novo genes. Unlike human-specific de novo protein coding gene, C20orf203, in which part of the ORF (194 amino acids) is formed by Alu repeats (48) , the ORF of GDNFOS does not contain any repeat sequence (RepeatMasker). GDNFOS transcript overlapping with GDNF mRNA might influence the higher ratios of GDNF -long and -short proforms in human brain. The cis-and trans-lncRNAs are more species-specific than protein coding genes (25, 54) . The GDNFOS3 peptide could indicate a young evolution event integrated into the pre-existing protein network of primates. Recently, Zhang et. al. have found that human young genes with novel functions are expressed in early development stages and likely contributed to the evolution of human neocortex (55) .
The existence of primate lncRNAs for BDNFOS and GDNFOS suggests that human plasticity mechanisms controlled by neurotrophic factors evolved rapidly after the split of rodent and primate lineages. Humans are more vulnerable to AD than mice who are resilient to the development of pathological plaques and tangles after knock-in of one of the dominant AD mutant genes such as PS1 M146V , APPswe, and Tau P301L (56). A tripartite regulation of GDNF, DNSP-11 and GDNFOS at both mRNA and protein levels might contribute to human intelligence and vulnerability of neurodegenerative diseases. The accelerated primate evolution of GDNF/GDNFOS locus adds more elements of the gene regulation networks in human brain. A. Human GDNF isoform expression using hGDNF-S in caudate as a reference. Primatespecific isoforms are marked by asterisks.
B. Rat GDNF isoform expression (n=3) using rGDNF-S in dorsal striatum as a reference.
Abbreviations: CAU, caudate; PUT, putamen; NAC, nucleus accumbens; SNR, substantia nigra; CTX, cortex; AMG, amygdala; HIP, hippocampus; HTH, hypothalamus; ISL, pancreatic islets; INT, intestine; KID, kidney; MUS, muscle; DST, dorsal striatum; PFC, prefrontal cortex; STM, stomach; TES, testis; LNG, lung; OVA, ovary; SPL, spleen. Table 2 Human 
